Bellicum Pharmaceuticals Inc.

(BLCM) Trade

By |

Profile

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company. Its research areas are cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases. The company's expertise is based on the inclusion of powerful molecular switches planned to eliminate, reduce, or activate therapeutic cells to increase efficacy and safety compared with existing cell therapies. Its pipeline portfolio includes adjunct T-cell therapy (BPX-501) to treat leukemias, lymphomas, and genetic blood diseases; CAR T cells technology (BPX-601) to treat prostate, pancreatic, bladder, esophagus, and gastric cancers; and T cell receptors (BPX-701) to treat blood cancers and solid tumors.

Contact Information

Website: www.bellicum.com
Email: crubin@troutgroup.com
Main Phone: +1 832 384-1100
Address: 2130 West Holcombe Boulevard
Address 2: Suite 800, Life Science Plaza
State: TX
City / Town: Houston
Country: USA
Postal Code: 77030

Issuer Information

Exchange: NSD
CEO: Richard A. Fair
Employees: 137
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.67 $ 0.08 (2.23%)
Last Price 3.67 Change $ 0.08 Change % 2.23 Tick N/A
Bid 3.50 Bid Size 2,100.00 Ask 3.58 Ask Size 700.00
Open 3.61 High 3.71 Low 3.50 Prev Close 3.59
Last Trade Volume 558,865 52 Wk Hi 10.26 52 Wk Low 3.50
Market Cap 159.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 43,361,159.00 EPS (TTM) -2.48 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 27
Number of Buys 1 8
Number of Sells 1 19
Net Activity 3794 -864685
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Alan A. Musso 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 23 23 23 23
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 18.83 18.83 18.83 18.83
Standard Deviation 3.66 3.66 3.66 3.66
Date of Most Recent Estimate 05/25/18 05/25/18 05/22/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 4
Moderate Buy 1 1 1 1
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.17 1.17 1.17 1.5